ALX Oncology Holdings Inc.
ALXO
$0.55
-$0.01-1.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.08M | 6.10M | 6.87M | 6.05M | 6.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.61M | 32.57M | 41.53M | 37.76M | 48.02M |
| Operating Income | -30.61M | -32.57M | -41.53M | -37.76M | -48.02M |
| Income Before Tax | -29.16M | -30.71M | -39.40M | -35.58M | -45.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.16M | -30.71M | -39.40M | -35.58M | -45.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.16M | -30.71M | -39.40M | -35.58M | -45.47M |
| EBIT | -30.61M | -32.57M | -41.53M | -37.76M | -48.02M |
| EBITDA | -30.40M | -32.35M | -40.86M | -37.55M | -47.82M |
| EPS Basic | -0.55 | -0.58 | -0.76 | -0.71 | -0.93 |
| Normalized Basic EPS | -0.35 | -0.36 | -0.48 | -0.44 | -0.58 |
| EPS Diluted | -0.55 | -0.58 | -0.76 | -0.71 | -0.93 |
| Normalized Diluted EPS | -0.35 | -0.36 | -0.48 | -0.44 | -0.58 |
| Average Basic Shares Outstanding | 52.80M | 52.69M | 51.83M | 50.12M | 49.00M |
| Average Diluted Shares Outstanding | 52.80M | 52.69M | 51.83M | 50.12M | 49.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |